John Kim

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 5

Top Topics

Top Venues

The American journal of gastroenterology

CPT: pharmacometrics & systems pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Min Seo Lee, Jihoon Lee, Minyoung Pang, John Kim, Hyunju Cha, Banyoon Cheon, Min-Koo Choi, Im Sook Song, Hye Suk Lee
In Vitro Metabolism and Transport Characteristics of Zastaprazan. Pharmaceutics 16 (6) (2024)
Eunsol Yang, Inyoung Hwang, Sang Chun Ji, John Kim, Seung Hwan Lee
Population pharmacokinetic analysis of zastaprazan (JP-1366), a novel potassium-competitive acid blocker, in patients and healthy volunteers. CPT: pharmacometrics & systems pharmacology (2024)
Jung-Hwan Oh, Hyun Soo Kim, Dae Young Cheung, Hang Lak Lee, Dong Ho Lee, Gwang Ha Kim, Suck-Chei Choi, Myung-Gyu Choi, Woo-Chul Chung, Ji Won Kim, Eunju Yu, Hyesoo Kwon, Jun Kim, John Kim, Hwoon Yong Jung
Randomized, Double-blind, Active-controlled Phase 3 Study to Evaluate Efficacy and Safety of Zastaprazan compared to Esomeprazole in Erosive Esophagitis. The American journal of gastroenterology (2024)
Min Seo Lee, Jihoon Lee, Minyoung Pang, John Kim, Hyunju Cha, Banyoon Cheon, Min-Koo Choi, Im Sook Song, Hye Suk Lee
In Vitro Metabolism and Transport Characteristics of Zastaprazan. Pharmaceutics 16 (6) (2024)
Jung-Hwan Oh, Hyun Soo Kim, Dae Young Cheung, Hang Lak Lee, Dong Ho Lee, Gwang Ha Kim, Suck-Chei Choi, Myung-Gyu Choi, Woo-Chul Chung, Ji Won Kim, Eunju Yu, Hyesoo Kwon, Jun Kim, John Kim, Hwoon Yong Jung
Randomized, Double-Blind, Active-Controlled Phase 3 Study to Evaluate Efficacy and Safety of Zastaprazan Compared With Esomeprazole in Erosive Esophagitis. The American journal of gastroenterology (2024)